Related Experiment Videos
Pilin-based anti-Pseudomonas vaccines: latest developments and perspectives
H Hahn1, P M Lane-Bell, L M Glasier
1Department of Biological Sciences, University of Alberta, Edmonton, Canada.
Behring Institute Mitteilungen
|February 1, 1997
Summary
Developing a Pseudomonas aeruginosa (Pa) vaccine is crucial. Targeting the pilin disulfide loop (DSL) showed promise, with multiple tandem insertions in Caulobacter crescentus S-layer proteins significantly boosting protective IgG titers in mice.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Pseudomonas aeruginosa (Pa) utilizes type-4 pilus adhesins for epithelial cell adherence, making it a significant virulence factor.
- The disulfide loop (DSL) adherence binding domain of pilin protein is a key target for blocking Pa colonization and infection.
Purpose of the Study:
- To evaluate the immunogenicity of pilin DSL peptides presented through various vaccine platforms.
- To develop an effective vaccine strategy against Pseudomonas aeruginosa by targeting its adherence mechanisms.
Main Methods:
- Constructed chimeric and integral fusion proteins, live vaccines (phage and bacterial display), and recombinant Caulobacter crescentus S-layer proteins displaying pilin DSL peptides.
- Immunized AB.Y/SnJ mice with these constructs and assessed serum IgG titers and protective immunity.
Main Results:
- Synthetic peptide conjugates offered limited strain-specific protection.
- Chimeric proteins and live vaccines (phage/bacterial display) failed to elicit significant protective IgG titers.
- Recombinant S-layer proteins with multiple tandem insertions of pilin DSL peptides resulted in a thousand-fold increase in serum IgG response.
Conclusions:
- Multiple tandem insertions of pilin DSL peptides, particularly within the Caulobacter crescentus S-layer, represent a promising strategy for a recombinant, cross-protective anti-Pseudomonas vaccine.
- Further development of S-layer based vaccines incorporating diverse pilin prototypes could enhance broad-spectrum protection against Pa infections.